Allogeneic T Cell Therapies Global Market Report 2025

Global Allogeneic T Cell Therapies Market Report 2024

Allogeneic T Cell Therapies Global Market Report 2025 – By Product Type (Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types), By Antigen Type (CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types), By Therapeutics Indications (Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Allogeneic T Cell Therapies Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Allogeneic T Cell Therapies Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Allogeneic T Cell Therapies Global Market Report 2025

Proud Members Of

Allogeneic T Cell Therapies Market Definition

Allogeneic T cell therapies are a type of medical treatment where T cells, a crucial component of the immune system, are obtained from a donor (rather than the patient) and used to target and destroy Cancer cells in the recipient. Allogeneic T-cell therapies are primarily used in the treatment of various cancers, particularly those that are difficult to treat with conventional methods.

The main types of allogeneic T cell therapies are chimeric antigen receptor (CAR) T cell therapies and T cell receptor (TCR) therapies. Chimeric antigen receptor (CAR) T-cell therapies are a type of immunotherapy where a patient's T-cells are genetically modified to target and destroy cancer cells. This treatment involves reprogramming T-cells to recognize specific proteins in cancer cells. The antigen types for these therapies include CD19, CD20, EgfrvIII, GD2, CD22, CD30, CD33, Meso, HER1, and others. These therapies are used for therapeutic indications such as cancer, autoimmune diseases, infectious diseases, and more, and are utilized by end users including hospitals, specialty clinics, research institutes, and others.

Allogeneic T Cell Therapies Market Segmentation

The allogeneic t cell therapiesmarket covered in this report is segmented –

1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types

2) By Antigen Type: CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types

3) By Therapeutics Indications: Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications

4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies

2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies

3) By Other Product Types: Engineered T Cell Therapies, NK Cell Therapies

Allogeneic T Cell Therapies Market Size and growth rate 2025 to 2029: Graph

Allogeneic T Cell Therapies Market Size 2025 And Growth Rate

The allogeneic t cell therapies market size has grown rapidly in recent years. It will grow from $1.16 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to regulatory approvals, increasing cancer prevalence, rising clinical trials, government funding, and a growing geriatric population.

Allogeneic T Cell Therapies Market Growth Forecast

The allogeneic t cell therapies market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to expanding indications, rising demand for cell-based immunotherapies, growing awareness about advanced therapies, increasing healthcare expenditure, and supportive reimbursement policies. Major trends in the forecast period include advancement in research and development activities, personalized medicine, off-the-shelf therapies, global market expansion, strategic partnerships, and regulatory landscape evolution.

Book your 30 minutes free consultation with our research experts

Allogeneic T Cell Therapies Market Driver: Increasing Cancer Cases Drive Demand For Innovative Therapies

The increasing cases of cancer are expected to propel the growth of the allogeneic T cell therapies market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. Cancer cases are rising due to factors such as longer lifespans, lifestyle changes, environmental exposures, infections, genetic factors, and changes in reproductive patterns, which collectively contribute to a higher incidence and detection of the disease. Allogeneic T cell therapies are used in cancer patients to target and kill cancer cells by infusing genetically engineered donor T cells that recognize specific tumor antigens. For instance, in May 2024, according to the National Cancer Institute, a US-based government agency, there were about 18.1 million cancer survivors in the United States. This figure is projected to rise to 22.5 million by 2032. By 2040, it's expected that the number of new cancer cases each year will reach 29.9 million, with cancer-related deaths estimated to increase to 15.3 million. Therefore, the increasing cases of cancer drive the allogeneic T cell therapies market.

Global Allogeneic T Cell Therapies Market Major Players

Major companies operating in the allogeneic t cell therapies market are Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Immatics NV, Sangamo Therapeutics Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Sorrento Therapeutics Inc., Autolus Therapeutics Plc, MaxCyte Inc., Tessa Therapeutics Pte Ltd., Cell Medica Inc., Enlivex Therapeutics Ltd., Cellectis SA, Adaptimmune Therapeutics Plc, Medigene AG, Celyad Oncology SA, Allogene Therapeutics Inc., Bellicum Pharmaceuticals Inc.

Global Allogeneic T Cell Therapies Market Trend: Innovative Solutions Enhanced Allogeneic T Cell Therapies Market Growth

Major companies operating in the allogeneic T cell therapies market are focused on developing innovative chimeric antigen receptor (CAR) T-cell therapy initiatives to enhance treatment efficacy and expand therapeutic options. Innovative chimeric antigen receptor (CAR) T-cell therapy initiatives refer to advanced approaches designed to enhance the effectiveness, accessibility, and delivery of CAR T-cell treatments for cancer. For instance, in October 2022, Allogene Therapeutics Inc., a US-based biotechnology company, launched CAR T Together, an innovative initiative to address the challenges of delivering and accessing CAR T therapies. The program focuses on simplifying clinical trial enrollment and fostering collaboration among oncologists to accelerate the development of allogeneic CAR T therapies. Unlike autologous therapies, which are customized from a patient's own cells, allogeneic therapies use T cells from healthy donors, enabling more efficient manufacturing processes.

Allogeneic T Cell Therapies Market Merger And Acquisition: AstraZeneca Plc Acquires Neogene Therapeutics Inc. To Enhance Oncology Pipeline

In January 2023, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Neogene Therapeutics Inc. for an undisclosed amount. Through this acquisition, AstraZeneca seeks to improve patient outcomes by advancing innovative medicines and strengthening its oncology capabilities, particularly in developing cutting-edge therapies for solid tumors that target cancer-specific mutations. Neogene Therapeutics Inc. is a US-based biotechnology company that provides allogeneic T-cell therapies.

Regional Outlook For The Global Allogeneic T Cell Therapies Market

North America was the largest region in the allogeneic T cell therapies market in 2024. The regions covered in the allogeneic T cell therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the allogeneic T cell therapies market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Allogeneic T Cell Therapies Market?

The allogeneic T cell therapies market includes revenues earned by entities providing services such as allogeneic CAR-t cell therapy, allogeneic TCR-t cell therapy, allogeneic NK or T cell therapy, off-the-shelf allogeneic t cell therapy, allogeneic virus-specific t cell therapy, and universal donor t cell therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Allogeneic T Cell Therapies Industry?

The allogeneic T cell therapies market research report is one of a series of new reports from The Business Research Company that provides allogeneic T cell therapies market statistics, including the allogeneic T cell therapies industry's global market size, regional shares, competitors with an allogeneic T cell therapies market share, detailed allogeneic T cell therapies market segments, market trends, and opportunities, and any further data you may need to thrive in the allogeneic T cell therapies industry. This allogeneic T cell therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Allogeneic T Cell Therapies Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.28 billion
Revenue Forecast In 2034	$1.85 billion
Growth Rate	CAGR of 9.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types 2) By Antigen Type: CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types 3) By Therapeutics Indications: Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications 4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegments: 1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies 2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies 3) By Other Product Types: Engineered T Cell Therapies, NK Cell Therapies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Immatics NV, Sangamo Therapeutics Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Sorrento Therapeutics Inc, Autolus Therapeutics Plc, MaxCyte Inc., Tessa Therapeutics Pte Ltd., Cell Medica Inc., Enlivex Therapeutics Ltd., Cellectis SA, Adaptimmune Therapeutics Plc, Medigene AG, Celyad Oncology SA, Allogene Therapeutics Inc, Bellicum Pharmaceuticals Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Allogeneic T Cell Therapies Market Characteristics

3. Allogeneic T Cell Therapies Market Trends And Strategies

4. Allogeneic T Cell Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Allogeneic T Cell Therapies Growth Analysis And Strategic Analysis Framework

5.1. Global Allogeneic T Cell Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Allogeneic T Cell Therapies Market Growth Rate Analysis

5.4. Global Allogeneic T Cell Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Allogeneic T Cell Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Allogeneic T Cell Therapies Total Addressable Market (TAM)

6. Allogeneic T Cell Therapies Market Segmentation

6.1. Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chimeric Antigen Receptor (CAR) T Cell Therapies

T Cell Receptor (TCR) Therapies

Other Product Types

6.2. Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CD 19

CD 20

Egfrvlll

GD2

CD22

CD30

CD33

Meso

HER1

Other Antigen Types

6.3. Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cancer

Autoimmune Diseases

Infectious Diseases

Others Therapeutics Indications

6.4. Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Research Institutes

Other End-Users

6.5. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

CD19-targeted CAR T Therapies

BCMA-targeted CAR T Therapies

CD22-targeted CAR T Therapies

6.6. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neoantigen-targeted TCR Therapies

Viral Antigen-targeted TCR Therapies

6.7. Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Engineered T Cell Therapies

NK Cell Therapies

7. Allogeneic T Cell Therapies Market Regional And Country Analysis

7.1. Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Allogeneic T Cell Therapies Market

8.1. Asia-Pacific Allogeneic T Cell Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Allogeneic T Cell Therapies Market

9.1. China Allogeneic T Cell Therapies Market Overview

9.2. China Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Allogeneic T Cell Therapies Market

10.1. India Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Allogeneic T Cell Therapies Market

11.1. Japan Allogeneic T Cell Therapies Market Overview

11.2. Japan Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Allogeneic T Cell Therapies Market

12.1. Australia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Allogeneic T Cell Therapies Market

13.1. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Allogeneic T Cell Therapies Market

14.1. South Korea Allogeneic T Cell Therapies Market Overview

14.2. South Korea Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Allogeneic T Cell Therapies Market

15.1. Western Europe Allogeneic T Cell Therapies Market Overview

15.2. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Allogeneic T Cell Therapies Market

16.1. UK Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Allogeneic T Cell Therapies Market

17.1. Germany Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Allogeneic T Cell Therapies Market

18.1. France Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Allogeneic T Cell Therapies Market

19.1. Italy Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Allogeneic T Cell Therapies Market

20.1. Spain Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Allogeneic T Cell Therapies Market

21.1. Eastern Europe Allogeneic T Cell Therapies Market Overview

21.2. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Allogeneic T Cell Therapies Market

22.1. Russia Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Allogeneic T Cell Therapies Market

23.1. North America Allogeneic T Cell Therapies Market Overview

23.2. North America Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Allogeneic T Cell Therapies Market

24.1. USA Allogeneic T Cell Therapies Market Overview

24.2. USA Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Allogeneic T Cell Therapies Market

25.1. Canada Allogeneic T Cell Therapies Market Overview

25.2. Canada Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Allogeneic T Cell Therapies Market

26.1. South America Allogeneic T Cell Therapies Market Overview

26.2. South America Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Allogeneic T Cell Therapies Market

27.1. Brazil Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Allogeneic T Cell Therapies Market

28.1. Middle East Allogeneic T Cell Therapies Market Overview

28.2. Middle East Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Allogeneic T Cell Therapies Market

29.1. Africa Allogeneic T Cell Therapies Market Overview

29.2. Africa Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Allogeneic T Cell Therapies Market Competitive Landscape And Company Profiles

30.1. Allogeneic T Cell Therapies Market Competitive Landscape

30.2. Allogeneic T Cell Therapies Market Company Profiles

30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Immatics NV Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sangamo Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Allogeneic T Cell Therapies Market Other Major And Innovative Companies

31.1. Poseida Therapeutics Inc.

31.2. Fate Therapeutics Inc.

31.3. Atara Biotherapeutics Inc.

31.4. Sorrento Therapeutics Inc

31.5. Autolus Therapeutics Plc

31.6. MaxCyte Inc.

31.7. Tessa Therapeutics Pte Ltd.

31.8. Cell Medica Inc.

31.9. Enlivex Therapeutics Ltd.

31.10. Cellectis SA

31.11. Adaptimmune Therapeutics Plc

31.12. Medigene AG

31.13. Celyad Oncology SA

31.14. Allogene Therapeutics Inc

31.15. Bellicum Pharmaceuticals Inc.

32. Global Allogeneic T Cell Therapies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allogeneic T Cell Therapies Market

34. Recent Developments In The Allogeneic T Cell Therapies Market

35. Allogeneic T Cell Therapies Market High Potential Countries, Segments and Strategies

35.1 Allogeneic T Cell Therapies Market In 2029 - Countries Offering Most New Opportunities

35.2 Allogeneic T Cell Therapies Market In 2029 - Segments Offering Most New Opportunities

35.3 Allogeneic T Cell Therapies Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Bristol-Myers Squibb Company Financial Performance

Table 79: Novartis AG Financial Performance

Table 80: Gilead Sciences Inc. Financial Performance

Table 81: Immatics NV Financial Performance

Table 82: Sangamo Therapeutics Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Allogeneic T Cell Therapies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR) T Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of T Cell Receptor (TCR) Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Allogeneic T Cell Therapies Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Allogeneic T Cell Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Allogeneic T Cell Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Allogeneic T Cell Therapies Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Allogeneic T Cell Therapies Market, Segmentation By Antigen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Allogeneic T Cell Therapies Market, Segmentation By Therapeutics Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Bristol-Myers Squibb Company Financial Performance

Figure 79: Novartis AG Financial Performance

Figure 80: Gilead Sciences Inc. Financial Performance

Figure 81: Immatics NV Financial Performance

Figure 82: Sangamo Therapeutics Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the digestive health supplements market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the protein purification and isolation market research report 2022 with industry size, share, segments and market growth

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Stem Cell Therapy Global Market Report 2025 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others), By End-Users (Hospitals And Clinics, Research Centers, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellular Immunotherapy Global Market Report 2025 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell and Gene Therapy Global Market Report 2025 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell Therapy Technologies Global Market Report 2025 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control), By End User (Life Science Companies, Research Institutes And Cell Banks) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cell & Gene Therapy Manufacturing Services Global Market Report 2025 – By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases), By Application (Commercial Manufacturing, Clinical Manufacturing), By End-user (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autologous Cell Therapy Global Market Report 2025 – By Therapy (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Source (Bone Marrow, Epidermis, Mesenchymal Stem Cells, Hematopoietic Stem Cells, Chondrocytes, Other Sources), By Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disorders, Autoimmune Disorders, Orthopedics, Wound Healing, Other Applications), By End User (Hospitals And Clinics, Ambulatory Centers, Academics And Research, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2025 – By Drug Class (Cisplatin, Carboplatin, 5-fluorouracil, Docetaxel, Paclitaxel, Methotrexate, Other Drugs), By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies), By Route of Administration (Oral, Parenteral, Other Routes), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Allogeneic T Cell Therapies market?

Allogeneic T cell therapies are a type of medical treatment where T cells, a crucial component of the immune system, are obtained from a donor (rather than the patient) and used to target and destroy cancer cells in the recipient. Allogeneic T-cell therapies are primarily used in the treatment of various cancers, particularly those that are difficult to treat with conventional methods. For further insights on the Allogeneic T Cell Therapies market, request a sample here

How will the Allogeneic T Cell Therapies market drivers and restraints affect the market dynamics? What forces will shape the Allogeneic T Cell Therapies industry going forward?

The Allogeneic T Cell Therapies market major growth driver - Increasing Cancer Cases Drive Demand For Innovative Therapies. For further insights on the Allogeneic T Cell Therapies market, request a sample here

What is the forecast market size or the forecast market value of the Allogeneic T Cell Therapies market?

The Allogeneic T Cell Therapies market size has grown strongly in recent years. The allogeneic t cell therapies market size has grown rapidly in recent years. It will grow from $1.16 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to regulatory approvals, increasing cancer prevalence, rising clinical trials, government funding, and a growing geriatric population. The allogeneic t cell therapies market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to expanding indications, rising demand for cell-based immunotherapies, growing awareness about advanced therapies, increasing healthcare expenditure, and supportive reimbursement policies. Major trends in the forecast period include advancement in research and development activities, personalized medicine, off-the-shelf therapies, global market expansion, strategic partnerships, and regulatory landscape evolution. For further insights on the Allogeneic T Cell Therapies market, request a sample here

How is the Allogeneic T Cell Therapies market segmented?

The allogeneic t cell therapiesmarket covered in this report is segmented –
1) By Product Type: Chimeric Antigen Receptor (CAR) T Cell Therapies, T Cell Receptor (TCR) Therapies, Other Product Types
2) By Antigen Type: CD 19, CD 20, Egfrvlll, GD2, CD22, CD30, CD33, Meso, HER1, Other Antigen Types
3) By Therapeutics Indications: Cancer, Autoimmune Diseases, Infectious Diseases, Others Therapeutics Indications
4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users
Subsegments:
1) By Chimeric Antigen Receptor (CAR) T Cell Therapies: CD19-targeted CAR T Therapies, BCMA-targeted CAR T Therapies, CD22-targeted CAR T Therapies
2) By T Cell Receptor (TCR) Therapies: Neoantigen-targeted TCR Therapies, Viral Antigen-targeted TCR Therapies
3) By Other Product Types: Engineered T Cell Therapies, NK Cell Therapies For further insights on the Allogeneic T Cell Therapies market, request a sample here

Which region has the largest share of the Allogeneic T Cell Therapies market? What are the other regions covered in the report?

North America was the largest region in the allogeneic T cell therapies market in 2024. The regions covered in the allogeneic T cell therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Allogeneic T Cell Therapies market, request a sample here.

Who are the major players in the Allogeneic T Cell Therapies market?

What are the key trends in the Allogeneic T Cell Therapies market?

Major trends in the Allogeneic T Cell Therapies market include Innovative Solutions Enhanced Allogeneic T Cell Therapies Market Growth. For further insights on the Allogeneic T Cell Therapies market, request a sample here.

What are the major opportunities in the Allogeneic T Cell Therapies market? What are the strategies for the Allogeneic T Cell Therapies market?

For detailed insights on the major opportunities and strategies in the Allogeneic T Cell Therapies market, request a sample here.

How does the Allogeneic T Cell Therapies market relate to the overall economy and other similar markets?

For detailed insights on Allogeneic T Cell Therapies's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Allogeneic T Cell Therapies industry?

For detailed insights on the mergers and acquisitions in the Allogeneic T Cell Therapies industry, request a sample here.

What are the key dynamics influencing the Allogeneic T Cell Therapies market growth? SWOT analysis of the Allogeneic T Cell Therapies market.

For detailed insights on the key dynamics influencing the Allogeneic T Cell Therapies market growth and SWOT analysis of the Allogeneic T Cell Therapies industry, request a sample here.